News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

AI Thinks Like Us – Flaws and All: New Study Finds ChatGPT Mirrors Human Decision Biases in Half the Tests
News Release

BALTIMORE, MD, April 1, 2025 – Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations showing biases like overconfidence of hot-hand (gambler’s) fallacy yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).

Read More
In 2025, you can’t have an effective democracy without data literacy
Media Coverage

You are swimming in an ocean of data and don’t even realize it. All around you are invisible amounts of data that would be staggering to try to comprehend. Thousands of smartphones and smart devices are talking to, sending and downloading vast amounts of data, video, audio, words, numbers, images, you name it. Everything from the latest movie on Netflix to someone’s radiology results from a cancer screening.

Read More
Shell Shocked: How Small Eateries Are Dealing With Record Egg Prices
Media Coverage

Mom-and-pop businesses are trying to adapt to the soaring cost of eggs. The owners of four egg-centric restaurants across the country show how they are coping with this threat to their livelihoods.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Leading the Pack Out of the Pandemic

Leading the Pack Out of the Pandemic

NC State University, March 3, 2021

Megan Jacob is a mother of three who just got her second dose of the COVID-19 vaccine. She’s also an associate professor in clinical microbiology and director of Diagnostic Laboratories at the NC State College of Veterinary Medicine (CVM). Now, under her leadership, the college is home to COVID-19 testing labs for the NC State community. With the laboratories capable of completing 8,000 tests per day — and current expectations for campus demand at about 11,000 tests per week — much of the university community’s health is in the hands of her and her lab team. “I’ve hired some really great people in our lab who, in their cover letters, say, ‘I just want to contribute to fighting the pandemic,’” says Jacob. “It has truly brought out some of the best in people.”

The Reason Nevada Isn't Receiving More Vaccine Doses Just Became Clear

The Reason Nevada Isn't Receiving More Vaccine Doses Just Became Clear

Las Vegas Review-Journal, March 3, 2021

Experts now say there’s a simple reason why Nevada’s COVID-19 vaccine allotment has seemed low for months. Fast-growing states have been disadvantaged due to the federal government’s reliance on old population data. Weekly vaccine allocations are proportional to each state’s estimated adult population recorded in the U.S. Census Bureau’s 2014-18 American Community Survey. The 2015-19 estimates show Nevada with a 1.9 percent larger adult population, one of the biggest increases in the nation. “We get a smaller share of the vaccines compared to what we should have because we’re using kind of older data, and Nevada has grown since then,” UNLV epidemiologist Brian Labus said. “The farther back you look, the greater the gap is going to be.” White House COVID-19 response coordinator Jeff Zients said Monday the allocation method will continue as the Johnson & Johnson vaccine comes online.

Getting Answers: Vaccination Timeline

Getting Answers: Vaccination Timeline

CBS 17, March 3, 2021

North Carolina went from getting its first COVID-19 case to its first vaccination in less than a year. Vaccine demand has now outweighed supply making appointments difficult to get. Many people are left wondering when it will be their chance to get a COVID-19 vaccine if they don’t fall in the priority groups. Dr. Julie Swann is the head of the N.C. State Industrial and Systems Engineering Department. She models pandemics and said we are still in the early stages of vaccinations. “If we we continued at the same rate, 70 percent of the population would receive a first dose by late summer, early fall so that’s a ways away,” said Swann. She said that timeline could be moved up if vaccine manufacturing speeds up, creating more supply. The introduction of the Johnson and Johnson vaccine could move up the timeline too as it only required a single dose, reaching Americans twice as fast.

FDA Approves Johnson & Johnson Vaccine, Another Valuable Tool Against Covid-19

FDA Approves Johnson & Johnson Vaccine, Another Valuable Tool Against Covid-19

The Smithsonian Magazine, March 2, 2021

On February 27, the United States Food and Drug Administration (FDA) issued emergency use authorization for the Johnson & Johnson Covid-19 vaccine in adults 18 years of age and older. The vaccine is now the third approved for use in the United States, adding another tool to help stymie the Covid-19 pandemic. Because Johnson & Johnson's vaccine doesn't use mRNA—as the previously approved vaccines from Moderna and Pfizer-BioNTech do—the vaccine provides several practical benefits. Only one dose is needed instead of two, which means fewer vaccination appointments for patients and reduced production demands. And the new vaccine doesn't require super-cold storage; it remains stable in regular refrigeration for three months.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine